FDA Approves Rezurock (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD)

FDA Approves Rezurock (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD) NEW YORK, NY / ACCESSWIRE / July 16, 2021 / Kadmon Holdings, Inc. (Nasdaq:KDMN) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezurock™ (belumosudil) 200 mg once daily (QD) for the treatment of adult and pediatric patients… Read More »

Journalists’ Topics Range From Rural Pharmacy Deserts to Opioid Overdoses

KHN senior Colorado correspondent Markian Hawryluk discussed how a rural Colorado town is crowdsourcing ways to get prescription medicines delivered on KUNC’s “Colorado Edition” on Monday. KHN Editor-in-Chief Elisabeth Rosenthal discussed how medical education changed during the pandemic on NPR’s “Here and Now” on Tuesday. KHN freelancer Amy Worden chatted about high vaccine hesitancy among… Read More »

Dr. Scott Gottlieb says U.S. is ‘vastly underestimating’ level of Covid delta spread

Dr. Scott Gottlieb told CNBC on Friday he believes the U.S. is significantly undercounting the number of Covid delta infections, making it difficult to know whether the highly transmissible strain is causing higher-than-expected hospitalization and death rates. “We don’t know what the denominator is right now,” Gottlieb said in an interview on “Squawk Box.” “I… Read More »